Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.

Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.

Conditions: Diabetes Mellitus, Type 2; Hypertension
Interventions: Drug: Carvedilol Controlled Release (CR); Drug: lisinopril
Sponsors: University at Buffalo; GlaxoSmithKline
Terminated

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 17, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments